# DIFLUPREDNATE
> **ANDA218191** · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2025-02-11
## Drug
- **FDA Application Number:** ANDA218191
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIFLUPREDNATE
- **Generic name:** DIFLUPREDNATE
- **Active ingredients:** DIFLUPREDNATE
- **Dosage form:** EMULSION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** UPSHER SMITH LABS
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2025-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218191)
---
*AI Analytics · CC0 1.0*